Clinical Trial Registration
Prospective Registration of Clinical Trials and Observational Studies · Also known as: trial registration, prospective registration, ClinicalTrials.gov, trial registry, ISRCTN
Clinical trial registration is the prospective documentation of a trial's key information (hypothesis, design, population, outcomes) in a public registry before enrollment begins or results are known. In 2005, the World Health Organization established the requirement that all clinical trials be registered in an internationally recognized registry before participant enrollment. The International Committee of Medical Journal Editors (ICMJE) made registration a condition for publication in major medical journals in 2005, updated in 2015. Primary registries include ClinicalTrials.gov (U.S.), ISRCTN (UK), EudraCT (EU), and others operating under WHO oversight. Registration serves to prevent selective outcome reporting, reduce publication bias, and enhance research transparency.
Read the full method
Sign in with a free account to read this section.
Method map
The neighbourhood of related methods — select a node to explore.
When to use it
Register all clinical trials before enrolling the first participant. Clinical trial is defined as a research study prospectively assigning participants to one or more health-related interventions to evaluate effects on health outcomes (includes drugs, devices, behavioral interventions, surgical procedures, but not observational studies without intervention). In practice: (1) Phase I-IV drug trials: mandatory registration before enrollment. (2) Device trials (FDA-regulated): mandatory registration. (3) Observational studies with a primary hypothesis: increasingly expected to register (though not formally required; ICMJE expects registration of observational studies published in major journals). (4) Behavioral intervention trials (e.g., psychotherapy, health education, lifestyle): registration is expected and increasingly required by funders and journals. (5) Pragmatic trials and quality improvement research: if the research has a rigorous protocol and aims to test a hypothesis (not routine quality improvement), registration is appropriate. Timing: register before enrolling the first participant; this is the gold standard. For trials already underway without registration, register as soon as possible (even mid-study). For completed trials not yet published, register before manuscript submission (many journals now require this). Do NOT register after results are available if you intend to submit results to the registry, as retrospective registration raises concerns about selective reporting (though retrospective registration is better than no registration).
Strengths & limitations
- Prevents outcome switching and selective reporting: pre-specifying the primary outcome in a public, immutable registry prevents researchers from changing outcomes after seeing results.
- Reduces publication bias: registry creates permanent record of all trials, including unpublished null results; systematic reviewers can identify trials that were conducted but never reported in literature.
- Enhances research transparency: readers and clinicians can access the registered protocol, compare registered outcome to reported results, and assess alignment.
- Deters research misconduct: researchers know that outcome specifications are public and permanent; this deterrent effect likely reduces p-hacking and selective reporting.
- Registries do not enforce outcome pre-specification compliance: while registration is mandatory for publication, enforcement is inconsistent. Some journals and institutions do not actively verify that reported primary outcomes match registered specifications.
- Selective outcome reporting can still occur: researchers might register the true primary outcome but then report secondary outcomes more prominently in publication, creating misleading emphasis despite technical compliance.
- Varied data quality: registry entries require self-reported information; completeness and accuracy vary. Some registrations are vague or missing key details, limiting transparency benefits.
- Requires researcher effort: registration adds to research start-up burden; for complex trials with many sites, coordination of registration across institutions can be time-consuming.
Frequently asked
Which trials must be registered and which are optional?
Registration is mandatory for all Phase I-IV clinical trials of drugs or devices before enrollment begins, as a legal requirement in the U.S. (FDA) and most countries. Registration is increasingly expected for all intervention trials (including behavioral, surgical, or health system interventions) by journals (ICMJE requirement), funders (NIH, EIC require it), and ethics committees. Purely observational studies (cohort, case-control, cross-sectional) do not require registration legally, but major journals now encourage or require registration of observational studies with a pre-specified hypothesis. If publishing in a major journal (JAMA, Lancet, NEJM, BMJ), expect requirement to register. When in doubt, register; it strengthens your research.
When should I register: before or after ethics approval?
Best practice: register BEFORE ethics committee submission. This ensures that the registered primary outcome aligns with the ethics committee-approved protocol. In practice, many researchers apply for ethics approval and register simultaneously (within a day or two). Minimum requirement: register BEFORE enrolling the first participant. You do NOT need ethics approval before registering, though having ethics approval demonstrates institutional review. If you have not yet received ethics approval, register anyway; it will list your ethics committee review as pending.
Can I change my primary outcome after registration if I have a good scientific reason?
Once results are known, changing the primary outcome is considered outcome switching and constitutes research misconduct. The purpose of pre-registration is to lock in the primary outcome before seeing data. However, if you change the outcome before analyzing the data (e.g., during active enrollment, before the database is locked and unblinded), you can amend the registration and it is less problematic (though the amendment is tracked, and reviewers will note the change). Best practice: specify the primary outcome carefully before registration and do not change it. If you realize post-registration (but pre-results) that the primary outcome needs modification, consult your ethics committee and make an amendment, clearly documenting the reason. Once results are known, do not change the primary outcome; instead, report the change transparently in your manuscript as a protocol amendment, not as outcome switching.
What is the difference between registering a trial and ethics committee approval?
Registration and ethics approval are separate processes. Ethics committee approval (IRB/REC review) is a legal requirement; it verifies that the trial is ethical and that participant rights are protected. Registration is an additional transparency requirement that documents the trial protocol publicly. Some trials are registered and never approved by an ethics committee (if unethical, for example); conversely, a trial could theoretically be approved ethically but not registered (though journals and funders would reject it). The two processes serve different functions: ethics review protects participants; registration protects research integrity.
Sources
- World Health Organization. (2005). Ensuring that Studies Are Prospectively Registered. International Clinical Trials Registry Platform (ICTRP) Statement. link ↗
- International Committee of Medical Journal Editors. (2015). Recommendations for the Conduct, Reporting, Editorship, and Publication of Scholarly Work in Medical Journals. JAMA, 314(20), 2142-2150. link ↗
- U.S. Food and Drug Administration. (2020). Expanded Access (Compassionate Use). Electronic Code of Federal Regulations Title 21, Section 312.300. link ↗
- De Angelis, C., Drazen, J. M., Frizelle, F. A., Haivas, G., Hebert, P. C., Ioannidis, J. P., & Schroeder, T. V. (2004). Clinical Trial Registration: A Statement from the International Committee of Medical Journal Editors. N Engl J Med, 351(12), 1250-1251. DOI: 10.1056/NEJMe048225 ↗
How to cite this page
ScholarGate. (2026, June 4). Prospective Registration of Clinical Trials and Observational Studies. ScholarGate. https://scholargate.app/en/research-ethics/clinical-trial-registration
Which method?
Set this method beside its closest kin and read them side by side — the library lays the books on the table; the choice is yours.
- Data Protection and Privacy in ResearchResearch Ethics↔ compare
- Ethics Committee Application ProcessResearch Ethics↔ compare
- Research with Vulnerable PopulationsResearch Ethics↔ compare
- Risk-Benefit Assessment in Research ProtocolsResearch Ethics↔ compare
- Types of Ethics Committees in ResearchResearch Ethics↔ compare